Tonghua Jinma (000766.SZ) announced first-half results, with net profit of 7.1046 million yuan to mother, a year-on-year decrease of 57.72%

According to Zhitong Finance App, Tonghua Jinma (000766.SZ) released its 2026 semi-annual report. During the reporting period, the company achieved revenue of 557 million yuan, a year-on-year decrease of 14.28%. Achieved net profit attributable to shareholders of listed companies of 7.1046 million yuan, a year-on-year decrease of 57.72%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 6.1171 million yuan, a year-on-year decrease of 57.54%. Basic earnings per share were $0.0074.

In the first half of the year, in the face of deepening pharmaceutical industry policies and changes in the market environment, the company, under the correct leadership of the board of directors and the unremitting efforts of all employees, was guided by innovation-driven strategies, accelerated the development and industrialization process of key products, steadily promoted lean management, continuously optimized the marketing system and channel layout, and strived to maintain steady development of operations and performance.